Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-03-06 Share Issue/Capital Cha…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Last day of trading in Warrants Series 1 issued in connection with the Rights Issue
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Lifecare ASA regarding the trading status of 'Warrants Series 1' issued during a rights issue. It specifies the last day of trading for these warrants on the Euronext Oslo Børs and provides details on the exercise period and potential dilution. This falls under capital structure changes and share-related announcements, specifically fitting the 'Share Issue/Capital Change' category as it pertains to the lifecycle of warrants issued in a capital raise.
2026-03-06 English
Lifecare ASA: Mandatory notification of trade - Attachment: 260305 PDMR Attachment Morten Foros Krohnstad.pdf
Director's Dealing Classification · 1% confidence The document follows the standard template for reporting transactions by persons discharging managerial responsibilities (PDMRs) under the Market Abuse Regulation (MAR). It explicitly identifies the individual (Morten Foros Krohnstad), their position (Chair of the Board), the nature of the transaction (purchase of warrants), and the transaction details. This is a classic 'Director's Dealing' notification.
2026-03-05 English
Lifecare ASA: Mandatory notification of trade - Attachment: Lifecare ASA- Mandatory notification of trade.pdf
Director's Dealing Classification · 1% confidence The document is a mandatory notification of trade regarding a primary insider (Chair of the Board, Morten Foros Krohnstad) purchasing warrants. This falls under the category of Director's Dealing (DIRS), as it reports personal share/warrant transactions by a company executive/director, and includes the required PDMR (Person Discharging Managerial Responsibilities) notification form reference.
2026-03-05 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 1% confidence The document is a mandatory notification of trade regarding a primary insider (Chair of the Board) purchasing warrants. While it mentions warrant exercise periods, the core purpose is to report a transaction by a director/insider, which falls under the 'Director's Dealing' category.
2026-03-05 English
Lifecare confirms 12-week implant stability under real-life conditions materially reduces durability risk ahead of first-in-human study - Attachment: Lifecare confirms 12-week implant stability unde
Regulatory Filings Classification · 1% confidence The document is a press release from Lifecare ASA announcing a technical milestone regarding their implantable glucose monitoring technology. It provides an update on clinical study progress and durability testing. Since it does not fit into specific financial reporting categories like 10-K, IR, or ER, and is not a report publication announcement, it falls under the general regulatory/corporate announcement category.
2026-03-05 English
Lifecare confirms 12-week implant stability under real-life conditions materially reduces durability risk ahead of first-in-human study
Regulatory Filings Classification · 1% confidence The document is a press release issued by Lifecare ASA announcing a technical milestone regarding the durability of their implantable glucose monitoring technology. It does not constitute a financial report, a regulatory filing, or a shareholder meeting document. As it is a corporate announcement regarding business operations and R&D progress that does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2026-03-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.